R

Relay Therapeutics

Drug discovery platform targeting protein motion

Director – Clinical Operations

Clinical Research OperationsPosted on Nov 10
Full-timeCambridge, MA, USANo salary listedIn-person

About the Job

Requirements

  • Bring 10+ years of experience in the biopharma or CRO industry, including significant experience leading global studies as a study lead or equivalent.
  • Have led global Phase 2 and/or Phase 3 oncology studies end to end; experience with registrational studies is strongly preferred.
  • Have breast cancer or solid tumor oncology experience.
  • Have a track record of hands-on CRO and vendor oversight in an outsourced model, including contracting, budget management and performance governance.
  • Have current knowledge of global regulatory and compliance requirements, including US CFR, EU CTR, and ICH GCP, and have supported inspections or audits.
  • Have the ability to deliver to aggressive timelines, using data, technology and creative problem-solving to accelerate enrollment and maintain data integrity.
  • Lead through influence, building alignment across functions and with external partners, and communicate clearly and confidently with senior leaders, investigators and vendors.
  • Manage multiple priorities with a high degree of attention to detail in a fast-paced, growing biotech environment.
  • Have line management or team leadership experience.
  • Hold a bachelor's degree in a scientific or health-related field.

Responsibilities

  • Serve as Global Study Lead, accountable for delivery of assigned breast cancer studies from protocol concept through study start-up, enrollment, database lock and clinical study report, on time, on budget and to quality.
  • Lead the cross-functional study team across Clinical Science, Medical, Biostatistics, Data Management, Clinical Supply, Regulatory, Safety, Quality and Translational; set priorities, drive decisions and escalate risks.
  • Provide operational and feasibility input to protocol design, country and site selection, and enrollment strategy, aligning study plans with the breast cancer clinical development strategy and corporate goals.
  • Own study integrated timelines, budget, forecasts, risk and mitigation plans, and key performance metrics; provide data-driven status updates to program and senior leadership.
  • Select, contract and oversee CROs and specialty vendors, including central labs, imaging, IRT and eCOA, holding partners accountable for performance and quality through governance and active issue management.
  • Drive enrollment and site performance globally using data and recruitment and retention approaches to accelerate timelines.
  • Build and maintain relationships with investigators, key opinion leaders, site staff and cooperative groups in the breast oncology community, and explain complex scientific and operational topics to these stakeholders.
  • Ensure inspection readiness and compliance with GCP, ICH and applicable global regulations, including oversight of the Trial Master File, monitoring strategy, protocol deviations and corrective/preventive actions.
  • Contribute Clinical Operations sections to regulatory and study documents, including protocols and amendments, IND/CTA submissions, briefing packages, NDA/MAA components, annual reports, study postings and clinical study reports.
  • Partner with Clinical Operational Excellence to apply and improve study systems, processes and SOPs, and share lessons learned across the breast cancer program and broader Clinical Operations team.
  • Lead, coach and develop clinical study managers, clinical trial associates and other study team members, and serve as a leadership role model within Clinical Development Operations.

Desired Qualifications

  • Experience with registrational studies.
  • Familiarity with endocrine therapy, targeted therapy combinations or the metastatic breast cancer treatment landscape.
  • An advanced degree.

About the Company

Relay Therapeutics

Drug discovery platform targeting protein motion

Relay Therapeutics uses its Dynamo platform to discover drugs by exploring how proteins move, enabling them to target proteins previously considered undruggable. The platform blends experimental data with computational modeling to identify and optimize therapeutic candidates, with a focus on precision oncology and genetic diseases. Its approach combines motion biology, data-driven design, and active partnerships (such as a worldwide license and collaboration with Genentech) with an internal drug pipeline. The company aims to bring life-changing medicines to patients by advancing clinical trials and securing licensing collaborations to fund and validate its therapies.

Company size
201-500
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2016

Recently Posted Jobs

Explore more opportunities at Relay Therapeutics

See more jobs